Comparison of the New Oral Anticoagulants and Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Systematic Review and Meta-Analysis

Comparison of the New Oral Anticoagulants and Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Systematic Review and Meta-Analysis

Abstract Introduction New oral anticoagulants (NOACs) are approved for use in nonvalvular atrial fibrillation (AF). Objectives This study aimed to evaluate the efficacy and safety of NOACs compared with warfarin in AF and valvular heart disease (VHD). Methods We identified randomized controlled tria...

Full description

Bibliographic Details
Main Authors: Yasmin de Souza Lima Bitar, Mansueto Gomes Neto, Jose Admirço Lima Filho, Larissa Vitória Pereira, Kethyren Santos Oliveira Travassos, Kevan M. Akrami, Leonardo Roever, Andre Rodrigues Duraes
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-05-01
Series:Drugs in R&D
Online Access:http://link.springer.com/article/10.1007/s40268-019-0274-z

Internet

http://link.springer.com/article/10.1007/s40268-019-0274-z

Similar Items